DAPT, monotherapy, or more? Rethinking antithrombotic strategies after percutaneous coronary intervention

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Davide Capodanno

University of Catania, Catania (Italy)

2 More presentations in this session

Presentation thumbnail

If the stent looks good, why do patients still fail? the case for anti-inflammatory therapy

Doctor J. Rymer (Durham, US)

Presentation thumbnail

Fix the plaque, fight the lipids: why low-density lipoproteins still matter after percutaneous coronary intervention

Professor F. Visseren (Utrecht, NL)

Access the full session

Session thumbnail

Beyond stenting: optimising adjunctive pharmacotherapy for myocardial infarction

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Congress Session

Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more

Congress Presentation

Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months: pro

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources